The antiphospholipid syndrome associated with hepatic vein thrombosis has usually been of the primary type; that is, the American Rheumatism Association criteria for the diagnosis of systemic ...

Hepatic vein thrombosis is caused by one or several thrombogenic conditions, of which myeloproliferative disorders are the most frequent. Thrombosis and its fibrous sequelae can affect the veins ...

Budd–Chiari syndrome (BCS) is caused by obstruction of hepatic ... vein thrombosis are indications for shunting. The therapeutic principle of portosystemic shunting is to convert the portal ...

It is also called hepatic artery embolisation. You might have it as a treatment for a neuroendocrine tumour ... You also have a drug called octreotide as a drip into a vein for 8 to 12 hours before ...

If you’re looking for a natural way to improve your blood circulation and support your circulatory health, CRYSTAL PEAKS NUTRITION Vein and Artery Care might be the right choice for you.

Explore how the liver functions, common liver conditions, and tips to maintain liver health through lifestyle changes like ...

az.vub.ac.be Accumulating evidence suggests that stellate cells are involved in the regulation of the liver microcirculation and portal hypertension. Activated hepatic stellate cells have the ...

The hepatoduodenal ligament was subsequently mobilized to access the afferent vessels of the right hepatic lobe. The right branch of the portal vein and the right hepatic artery were identified and ...

These guidelines on transjugular intrahepatic portosystemic stent-shunt (TIPSS) in the management of portal hypertension have been commissioned by the Clinical Services and Standards Committee (CSSC) ...

aInstitute of Liver Studies, King's College Hospital National Health Services Foundation Trust, London, UK bFetal Medicine Research Unit, King's College Hospital National Health Services Foundation ...

renal and hepatic dysfunction. In addition, the measurement of these variables requires the use of invasive devices, such as a central venous catheter for CVP and a pulmonary artery catheter for PAOP.